hepatitis C drug

Hepatitis C drug denied to many Medicaid patients

A new study shows that nearly half of Medicaid patients requiring a cutting-edge hepatitis C drug have been denied due to tight controls from states as well as the high cost of the drugs. Roughly 46 percent of Medicaid patients were denied the new hepatitis C drug that could greatly improve their condition, possible even ...click here to read more